PTPRC and neoplasm: However, we found more EpCAM + CD45- tumor cells cells/ml in patients without previous oncologic treatment than in those that had received it (7.47(1.94–21.23) × 103 cells/ml vs 1.26(0.05–3.22) × 103 cells/ml, p = 0.02; respectively).